Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...
WASHINGTON (AP) — The Justice Department has agreed to refrain from publicly identifying any FBI agents whose conduct is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback